Important: The POPLINE website will retire on September 1, 2019. Click here to read about the transition.

Your search found 1770 Results

  1. 1

    Perforation of the anterior cervix by the threads of an intrauterine device.

    Boog K; Kumar V

    BMJ Sexual and Reproductive Health. 2018 Oct; 44(4):314-315.

    Add to my documents.
  2. 2
    Peer Reviewed

    Taking the provider "out of the loop:" patients' and physicians' perspectives about IUD self-removal.

    Amico JR; Bennett AH; Karasz A; Gold M

    Contraception. 2018 Oct; 98(4):288-291.

    OBJECTIVE: This study describes the perspectives of patients and providers about intrauterine device (IUD) self-removal. STUDY DESIGN: This qualitative study is a subanalysis of two datasets from a single project, which included semistructured individual interviews with 15 patients and 12 physicians. We derived the data for this analysis from portions of the interviews pertaining to IUD self-removal and provider removal. We analyzed data using deductive and inductive techniques to perform content and thematic analyses. RESULTS: The majority of patients and physicians cited both concerns about and potential benefits of IUD self-removal. Patients cited concerns about safety as the reason they did not wish to remove their own IUD, but physicians did not share these concerns; instead, physicians were apprehensive about not being involved in the discussion to remove the IUD. Both patients and physicians valued having the provider "in the loop" and reported fears about hasty or coerced removal. CONCLUSIONS: IUD self-removal is an option that some patients may be interested in. Addressing concerns about safety may make self-removal more appealing to some patients. Addressing physicians' concern about "hasty" removal may require additional training so that providers are better able to support patients' decision making around contraceptive use. IMPLICATIONS: The option of self-removal could have a positive impact on reproductive autonomy and patient decision making. Copyright (c) 2018. Published by Elsevier Inc.
    Add to my documents.
  3. 3
    Peer Reviewed

    The case for routine Gram stain following invasive prenatal procedures with retained intrauterine device.

    Lo TK; So CH; Kan AS; Yao H; Lam BH

    Journal of Obstetrics and Gynaecology. 2018 Jun 8; 1-2.

    Despite a high colonisation rate of 38% in the female lower genital tract (DiGiulio 2012), Candida seldom causes chorioamnionitis in pregnancy. The candida species (including albicans, glabrata and parapsilosis) is an opportunistic pathogen. A recent review found that most reported cases had underlying risk factors, such as conception by in vitro fertilisation, presence of a retained intrauterine device (IUD) or cervical cerclage (Garcia-Flores et al. 2016). It called for consideration of this entity when an intra-amniotic infection is suspected in the at-risk cases (Garcia-Flores et al. 2016). The reported outcome of candida chorioamnionitis is poor, particularly in the cases with an extremely low-birth weight (Barton et al. 2017). In this report, the authors describe a case of pregnancy loss following a second-trimester amniocentesis and highlight the need to actively exclude this possibility when performing invasive prenatal procedures for the at-risk cases, particularly those with IUD.
    Add to my documents.
  4. 4

    Colonoscopic Removal of an Intrauterine Device That Had Perforated the Rectosigmoid Colon.

    Huh JM; Kim KS; Cho YS; Suh DK; Lee JU; Baek SD; Moon SK

    Annals of Coloproctology. 2018 Apr; 34(2):106-108.

    The intrauterine device (IUD) is a widely used contraceptive method. One of the most serious and rare complications of using an IUD is colon perforation. We report a case of colonoscopic removal of an IUD that had perforated into the rectosigmoid colon in a 42-year-old woman who presented with no symptoms. Colonoscopy showed that the IUD had penetrated into rectosigmoid colon wall and that an arm of the IUD was embedded in the colon wall. We were able to remove the IUD easily by using colonoscopy. The endoscopic approach may be considered the first choice therapy for selected patients.
    Add to my documents.
  5. 5

    Combined Laparoscopic and Cystoscopic Retrieval of Forgotten Translocated Intrauterine Contraceptive Device.

    Alabi TO; Keshavamurthy M; Ahmed S; Ojewola RW; Jain M; Tijani KH

    Nigerian Journal of Surgery. 2018 Jan-Jun; 24(1):48-51.

    The most commonly used long-term reversible female contraception is intrauterine contraceptive device (IUCD). Its use is however associated with documented complications. Uterine perforation, though rare, is arguably the most surgically important of all these complications. We report a case of a 48-year-old para 4(+0) (4 alive) woman who had IUCD insertion 17 years earlier and had forgotten she had the device having had two children thereafter. The IUCD was subsequently translocated through the dome of the bladder into the peritoneal cavity with calculus formation around the tail and thread of the IUCD in the urinary bladder causing recurrent urinary tract infection. This "Collar Stud" effect made either cystoscopic or laparoscopic retrieval alone unsuccessful necessitating a combined approach. This case report highlights the need for a combined laparoscopic and cystoscopic approach in the retrieval of the unusual presentation of translocated IUCD.
    Add to my documents.
  6. 6
    Peer Reviewed

    Relationship between copper IUD complications and ultrasonographic findings.

    Fadiloglu S; Dilbaz B; Fadiloglu E; Dilbaz S

    Archives of Gynecology and Obstetrics. 2018 Apr; 297(4):989-996.

    OBJECTIVE: Intrauterine device (IUD) is a widely used long-acting contraceptive method; however, the side-effects related to IUD may lead to method discontinuation. The aim of this study is to evaluate the relation between the most common side-effects of IUD use; mainly dysmenorrhea, menorrhaghia, pelvic cramping and the relation of these complications with the position of the IUD device within the cavity and uterine dimensions evaluated by transvaginal ultrasonography. MATERIAL AND METHOD: Two hundred and eighty-four patients who had Cu-T380A IUD insertion at the Family Planning Clinic of a tertiary health center were evaluated at insertion and 6 and 12 weeks after the insertion. Demographic characteristics, medical history, symptoms and findings of the gynecological examination were recorded. Transvaginal ultrasonographic measurement of the uterine dimensions, the distance between the tip of the Cu-IUD and the fundus, myometrium and endometrium were measured to evaluate the displacement of the IUD. The relationship between the symptoms and IUD displacement diagnosed by ultrasonographic examination were investigated. RESULTS: Two hundred and sixty-seven patients were followed-up for 12 weeks as the remaining 16 had partial or complete IUD expulsion. A statistically significantly shorter uterine length was measured in patients who complained of menorrhagia in comparison to the ones without this complaint (54.27 +/- 6.11 vs 60.25 +/- 10.52 mm, p = 0.02) while uterine length was similar in patients with or without dysmenorrhea at 12 weeks (59.60 +/- 10.25 vs 60.33 +/- 10.68 mm, p = 0.71). The distances between the tip of the IUD and the endometrium, myometrium and the uterine fundus, were statistically and significantly longer in patients who experienced pelvic cramping at 3rd month, showing a downward movement of the IUD. (Endometrium; 0.29 +/- 0.72 vs 0.45 +/- 0.35 mm, p = 0.02, Myometrium; 1.25 +/- 1.39 vs 2.38 +/- 2.26 mm p < 0.05, Fundus; 1.68 +/- 2.39 vs 2.92 +/- 1.78 mm, p < 0.05). CONCLUSION: A shorter uterine cavity length seems to be a predictor of menorrhagia in patients with Cu-T 380A IUD. Patients experiencing pelvic cramping with IUD are more susceptible for IUD expulsion as the downward movement of IUD is more prominent in these patients.
    Add to my documents.
  7. 7
    Peer Reviewed

    Correction to: Trends in use of and complications from intrauterine contraceptive devices and tubal ligation or occlusion.

    Howard B; Grubb E; Lage MJ; Tang B

    Reproductive Health. 2017 Oct 06; 14(1):126.

    As result of a query from a reader, the authors reviewed the data in Table 2 of the original article and found a number of errors in the prior construction of this data table. A formatting error has also been noticed in Table 1.
    Add to my documents.
  8. 8

    [Intrauterine device: about a rare complication and literature review] Le dispositif intra-uterin: a propos d'une complication rare et revue de la litterature.

    Kallat A; Ibrahimi A; Fahsi O; El Sayegh H; Iken A; Benslimane L; Nouini Y

    Pan African Medical Journal. 2017; 27:193.

    The intrauterine device (IUD) is the most common contraceptive method used in the world. Transuterine migration is a rare complication, accounting for 1/350 - 1/10000 insertions in the literature. We report the case of a 40-year old patient, who had had an IUD insertion 12-year before, presenting with pelvic and right lower back pain associated with intermittent hematuria and burning during urination. Radiological assessment showed calcific deposits on intra bladder IUD. The patient underwent cystostomy, without any difficulty, allowing stone and IUD extraction. A urinary catheter was left in place for 5 days and then withdrawn. The postoperative course was uneventful.
    Add to my documents.
  9. 9

    Early pregnancy likely caused by an intravesical intrauterine device.

    Shen JK; Ko EY; Staack A

    Canadian Journal of Urology. 2016 Oct; 23(5):8487-8490.

    A 42-year-old female with remote history of intrauterine device (IUD) placement presented with gross hematuria, urinary urgency, and dyspareunia. Cystoscopy showed an encrusted, free-floating intravesical foreign body consistent with a heavily calcified IUD. It was removed endoscopically using holmium laser cystolitholapaxy. The patient remained symptom free postoperatively. While most intravesical IUDs are thought to be the result of migration after several months, this patient became pregnant within 4 weeks after initial insertion. Therefore this may represent a case either of early intravesical migration or of accidental IUD placement into the bladder at the time of initial insertion.
    Add to my documents.
  10. 10

    Screening for bacterial vaginosis before intrauterine device insertion at a family planning clinic in south-west Nigeria.

    Akinajo OR; Bello FA; Bello OO; Olayemi OO

    Nigerian Postgraduate Medical Journal. 2017 Apr-Jun; 24(2):75-80.

    AIM: This study determined the prevalence of bacterial vaginosis (BV) among clients before insertion of intrauterine device (IUD) and compared the incidence of complications between participants who were positive and negative for BV. PATIENTS AND METHODS: This was an observational cohort study that was performed between May 2014 and September 2014. A total of 360 women were recruited and followed up for 1 month. High vaginal swabs were obtained from each participant pre-insertion of the IUD and 1 month post-insertion. BV was diagnosed using Nugent's scoring. Data were collected, collated and analysed using frequency distributions and Chi-square test as appropriate. The level of statistical significance was P< 0.05. RESULTS: The prevalence of BV was 33.3%. The complication rate was 23.9% in which 30.5% complication rate was seen among participants positive for BV and 22.5% among participants negative for BV (P = 0.192). This was done with respect to four primary clinical outcomes. The incidence of BV one month after IUD insertion was 11.5%. CONCLUSION: The prevalence of BV was within the range reported in other populations. The complication rate appeared high; however, the differences in proportion between women positive and negative for BV were not statistically significant.
    Add to my documents.
  11. 11
    Peer Reviewed

    Management of Intrauterine Contraception in Early Pregnancy.

    Ramesh SS; Charm S; Kalinowski A; Liberty AL; Stuart GS

    Southern Medical Journal. 2017 Aug; 110(8):550-553.

    OBJECTIVES: Women with rare intrauterine contraception (IUC) failures are advised to have their IUC removed because of the risk of poor obstetric outcomes with a retained IUC. Specifics regarding IUC removal in early pregnancy including techniques for removal, rates of success, and immediate pregnancy outcomes following removal are not well described, however. The objective of this study was to identify women with an IUC in early pregnancy examined at a tertiary care center with the primary objective of describing IUC removal attempts, IUC removal successes, and pregnancy outcomes at 20 weeks following IUC removal. METHODS: Case series of women with concurrent IUC and early pregnancy who presented to a tertiary care ultrasound center by 12 weeks' gestation. RESULTS: A total of 3116 women had an early pregnancy ultrasound during the study period. Nineteen (19/3116, 0.61%) women underwent ultrasounds that identified a pregnancy before 12 weeks and an IUC in the uterus. A copper IUC was identified in 11 women (11/19, 58%) on their first ultrasound, and a levonogestrel IUC was identified in 5 women (5/19, 26%). Seventeen (17/19, 88%) women attempted to remove their IUC; 11 of 69 (69%) were successfully removed on the first attempt. Fourteen (14/19; 74%) women with an IUC examined by 12 weeks' gestation had an ongoing pregnancy at 20 weeks compared with 1782 (1782/2678, 67%; P = 0.209) women without an IUC. CONCLUSIONS: Pregnancy with IUC is rare. Among the 19 women who were found to have an in situ IUC and early pregnancy, most had a successful IUC removal and had an ongoing pregnancy at 20 weeks' gestation. In our case series, IUC removal in the first trimester was a straightforward procedure and likely successful.
    Add to my documents.
  12. 12

    A Rare Cause of Acute Appendicitis: Migration of an Intrauterine Device.

    Parlakgumus A; Parlakgumus HA; Ezer A

    Journal of the College of Physicians and Surgeons. 2017 May; 27(5):323-324.

    Add to my documents.
  13. 13

    An unusual case of a forgotten intrauterine contraceptive device for 25 years presented with ectopic pregnancy at AMDA Hospital, Damak, Nepal.

    Budhathoki B; Sharma P; Dhakal N; Sah R

    Birat Journal of Health Sciences. 2017 Jan-Apr; 2(1):142-144.

    Intrauterine contraceptive device (IUCD), Copper T-380A, is widely used by more than one million women around the world. It is a long acting, reversible device with higher safety, low cost and low failure rate profile. Hereby, we reported a case of ectopic pregnancy with a forgotten IUCD. She was a 42 year woman who had forgotten the IUCD placed in her uterus 25 years back. She was totally unaware of the follow up visits, its removal and that IUCD was causing a problem to conceive for the second time. The inserted IUCD was incidentally discovered on ultrasonography, when she presented with history of lower abdominal pain and vaginal bleeding. On investigation, she had right tubal pregnancy with moderate fluid in pelvic cavity. So, emergency laparotomy was performed followed by right salphingectomy and removal of IUCD.
    Add to my documents.
  14. 14

    Long-Acting Reversible Contraception. Contracepcao reversivel de longa acao.

    Machado RB; Monteiro IMU; Magalhaes J; Guazzelli CAF; Brito MB; Finotti MF; Lubianca JN; Sakamoto LC; Franceschini SA

    Revista Brasileira de Ginecologia e Obstetricia. 2017 Jun; 39(6):294-308.

    Unwanted pregnancy is a major public health problem both in developed and developing countries. Although the reduction in the rates of these pregnancies requires multifactorial approaches, increasing access to long-acting contraceptive methods can contribute significantly to change this scenario. In Brazil, gynecologists and obstetricians play a key role in contraceptive counseling, being decisive in the choice of long-acting reversible methods, characterized by intrauterine devices (IUDs) and the contraceptive implant. The vast scope due to the reduced number of situations to indicate long-acting methods should be emphasized in routine contraceptive counseling. On the other hand, gynecologists and obstetricians should adapt the techniques of insertion of long-acting methods, and engage in facilitating conditions to access these contraceptives through public and private health systems in Brazil. This study is part of a project called Diretrizes e Recomendacoes FEBRASGO (Guidelines and Recommendations of the FEBRASGO - Brazilian Federation of Gynecology and Obstetrics Associations from the Portuguese acronym). It aims to review the main characteristics of long-acting contraceptives and critically consider the current situation and future prospects to improve access to these methods, proposing practical recommendations of interest in the routine of gynecologists and obstetricians. Thieme Revinter Publicacoes Ltda Rio de Janeiro, Brazil.
    Add to my documents.
  15. 15
    Peer Reviewed

    Safety issue with TT380 Slimline intrauterine contraceptive device.

    Trewinnard K

    Journal of Family Planning and Reproductive Health Care. 2017 Jul; 43(3):241-242.

    Add to my documents.
  16. 16
    Peer Reviewed

    The safety of intrauterine devices in breastfeeding women: a systematic review.

    Berry-Bibee EN; Tepper NK; Jatlaoui TC; Whiteman MK; Jamieson DJ; Curtis KM

    Contraception. 2016 Dec; 94(6):725-738.

    OBJECTIVES: To investigate levonorgestrel (LNG)-releasing and copper-bearing (Cu) intrauterine device (IUD) safety among breastfeeding women and, for Cu-IUD use, breastfeeding performance and infant health. STUDY DESIGN: Systematic review. METHODS: We searched PubMed, Embase, Cochrane Library and for articles through January 2016. We included studies of Cu-IUD or LNG-IUD users comparing IUD-specific (perforation, expulsion) and other contraceptive-related (infection, removal/cessation due to bleeding/pain and other adverse events) outcomes for breastfeeding vs. non-breastfeeding women. We also included studies of breastfeeding women comparing contraceptive-related outcome for IUD-users vs. other contraceptive-method users. Finally, we included studies comparing breastfeeding outcomes among Cu-IUD users to users of other nonhormonal contraceptives or no contraception. RESULTS: Of 548 articles identified, 23 (16 studies) met the inclusion criteria. Two studies suggested that the risk of IUD perforation was 6-10 times higher among breastfeeding vs. non-breastfeeding women. Seven studies suggested that risks for other adverse events were similar or lower among breastfeeding vs. non-breastfeeding women. Three studies among breastfeeding women found no increased risk of adverse events in IUD users vs. nonusers. Breastfeeding performance and infant growth were similar for Cu-IUD users and users of other nonhormonal methods or no contraception. CONCLUSION: Overall, risks for adverse events among IUD users, including expulsion, pain and removals, were similar or lower for breastfeeding women vs. non-breastfeeding women. Uterine perforation with IUDs, while rare, appeared more frequent among breastfeeding women. No evidence indicated that Cu-IUD use in breastfeeding women influences breastfeeding performance or infant growth. Copyright (c) 2016 Elsevier Inc. All rights reserved.
    Add to my documents.
  17. 17
    Peer Reviewed

    The Challenging Intrauterine Contraceptive: In-office Hysteroscopic Approach.

    Di Spiezio Sardo A; da Cunha Vieira M; Scognamiglio M; Zizolfi B; Nappi C; de Angelis C

    Journal of Minimally Invasive Gynecology. 2016 May-Jun; 23(4):469.

    STUDY OBJECT: To describe 3 cases of misplaced or retained Intrauterine Contraceptive (IUC) that were successfully resolved by hysteroscopy performed in an ambulatory setting using miniaturized electrosurgical and mechanical operative instruments. DESIGN: Step-by-step description of the technique using slides, pictures, and video (educative video) (Canadian Task Force classification III). SETTING: Misplaced or retained IUC may be related to several causes; incorrect insertion is the leading cause. In these cases, patients may complain of abnormal bleeding, pelvic pain, or pregnancy or they may remain asymptomatic. When a displaced IUC is suspected, transvaginal ultrasonography is the primary investigation followed by radiography in cases in which the IUC is not seen within the uterus. Additional imaging such as computed tomographic scanning or magnetic resonance imaging may be needed. Hysteroscopy represents the gold standard for diagnostic clarification and management of a dislocated or embedded IUC. INTERVENTIONS: The hysteroscopic approach of the 3 cases was the following: removal of a partially perforating IUD in the cesarean scar pouch, repositioning of a dislocated IUS in the isthmocele, and removal of an embedded IUS in the cornual area. The procedures were performed in an ambulatory setting using a 5-mm continuous flow hysteroscope and vaginoscopic approach without any analgesia and/or anesthesia. The alternate use of mechanical and electrosurgical 5F instruments allowed us to separate the IUC from the myometrial uterine wall, respecting the healthy myometrium and without causing significant patient discomfort or complications. CONCLUSION: The possibility of using miniaturized electrosurgical and mechanical instruments with small-diameter hysteroscopes offers the possibility of an effective, safe, cost-efficient, and well-tolerated removal or repositioning of a misplaced or retained IUC. This minimally invasive approach can be performed in an office setting to avoid more invasive and traumatic approaches. Copyright (c) 2016 AAGL. Published by Elsevier Inc. All rights reserved.
    Add to my documents.
  18. 18
    Peer Reviewed

    Colonic obstruction secondary to Actinomyces.

    Jimenez Moreno MA; Sanchez Pedrique I; Obregon Martinez E

    Revista Espanola De Enfermedades Digestivas. 2017 Jun 19; 109

    Actinomycosis is an uncommon granulomatous infection by Gram-positive anaerobic bacteria of the genus Actinomyces. A. israelii is a major human pathogen. The most frequent locations for colonization are cervicofacial (50%), abdominal (20%) and thoracic (15-20%). The abdominal actinomycosis predisposing factors include recent surgery, trauma and neoplasias. Certain cases have been associated with the intrauterine contraception device (IUD).
    Add to my documents.
  19. 19
    Peer Reviewed

    Routine provision of intrauterine contraception at elective cesarean section in a national public health service: a service evaluation.

    Heller R; Johnstone A; Cameron ST

    Acta Obstetricia Et Gynecologica Scandinavica. 2017 Sep; 96(9):1144-1151.

    INTRODUCTION: We conducted a prospective health service evaluation to assess the feasibility and acceptability of routinely offering insertion of intrauterine contraception (IUC) at cesarean section in a maternity setting in the UK. MATERIAL AND METHODS: One month before scheduled cesarean section, women were sent information about postpartum contraception including the option of insertion of IUC at cesarean. Women choosing IUC (copper intrauterine device or levonorgestrel intrauterine system) were followed up in person at six weeks; telephone contact was made at three, six and 12 months postpartum. Our main outcome measures were uptake of IUC and complications by six weeks. Secondary outcomes were continuation and satisfaction with IUC at 12 months. RESULTS: 120/877 women opted to have IUC (13.7%), of which 114 were fitted. By six weeks, there were seven expulsions (6.1%). The expulsion rate by one year was 8.8%. There were been no cases of uterine perforations and one case of infection (0.8%). Follow up rates were 82.5% at 12 months, and continuation rates with IUC at 12 months were 84.8% of those contacted. At 12 months 92.7% of respondents asked were either 'very' or 'fairly' happy with their IUC. CONCLUSIONS: Routine provision of IUC at elective cesarean for women in a public maternity service is feasible and acceptable to women. It is associated with good uptake and good continuation rates for the first year. This could be an important strategy to increase use of IUC and prevent short inter-pregnancy intervals and unintended pregnancies. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.
    Add to my documents.
  20. 20
    Peer Reviewed

    Trends in use of and complications from intrauterine contraceptive devices and tubal ligation or occlusion.

    Howard B; Grubb E; Lage MJ; Tang B

    Reproductive Health. 2017 Jun 08; 14(1):70.

    BACKGROUND: Long-acting reversible contraceptives such as intrauterine devices (IUDs) are highly effective in preventing pregnancy, cost effective, and increasing in popularity. It is unclear whether changes in IUD use are associated with changes in rates of irreversible tubal sterilization. In this analysis, we evaluate changes in rates of tubal sterilization, insertion of copper or levonorgestrel (LNG) IUDs, and related complications over time. METHODS: Data were obtained from a retrospective claims database (OptumTM ClinformaticsTM Data Mart) of women aged 15 to 45 years who underwent insertion of copper or LNG IUD or tubal sterilization between 1/1/2006 and 12/31/2011. Outcomes of interest included annual rates of insertion or sterilization and annual rates of potential complications and side effects. RESULTS: The number of women included in the analysis each year ranged from 1,870,675 to 2,016,916. Between 2006 and 2011, copper IUD insertion claim rates increased from 0.18 to 0.25% and LNG IUD insertion claim rates increased from 0.63 to 1.15%, while sterilization claims decreased from 0.78 to 0.66% (P < 0.0001 for all comparisons). Increases in IUD insertion were apparent in all age groups; decreases in tubal sterilization occurred in women aged 20 to 34 years. The most common side effects and complications were amenorrhea (7.36-11.59%), heavy menstrual bleeding (4.85-15.69%), and pelvic pain (11.12-14.27%). Significant increases in claims of certain complications associated with IUD insertion or sterilization were also observed. CONCLUSION: Between 2006 and 2011, a decrease in sterilization rates accompanied an increase in IUD insertion rates, suggesting that increasing numbers of women opted for reversible methods of long-term contraception over permanent sterilization.
    Add to my documents.
  21. 21
    Peer Reviewed

    Pregnant with a perforated levonorgestrel intrauterine system and visible threads at the cervical os.

    Howard DL; Beasley LM

    BMJ Case Reports. 2017 May 22; 2017

    We present a case in which a patient presented with a pregnancy of unknown location and normally rising human chorionic gonadotropin (hCG) levels but with a levonorgestrel intrauterine device (LNG-IUD) present. The LNG-IUD had been placed 4.5 years ago. Although unintended, this pregnancy was desired. Strings were clearly visible and initial 2D ultrasound suggested intrauterine location of the LNG-IUD. The LNG-IUD could not be removed however. The patient was managed expectantly with close follow-up, serial beta-hCGs and serial ultrasounds until definitive diagnosis of the location of the pregnancy. The patient was diagnosed with an ectopic pregnancy and during laparoscopy the body of the IUD was noted in the posterior cul-de-sac. When patients present with multiple competing clinical problems it is important to look at the patient as a whole, taking into account their desires, in order to construct a cohesive management plan. (c) BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
    Add to my documents.
  22. 22

    Abdominal and pelvic actinomycosis due to longstanding intrauterine device: a slow and devastating infection.

    Nakahira ES; Maximiano LF; Lima FR; Ussami EY

    Autopsy and Case Reports. 2017 Jan-Mar; 7(1):43-47.

    Actinomycosis is a chronic or subacute bacterial infection characterized by large abscess formation, caused mainly by the gram-positive non-acid-fast, anaerobic, or microaerophilic/capnophilic, obligate parasites bacteria from the Actinomyces genus. Although pelvic inflammatory disease is an entity associated with the longstanding use of intrauterine devices (IUDs), actinomycosis is not one of the most frequent infections associated with IUDs. We present the case of a 43-year-old female patient who was referred to the emergency facility because of a 20-day history of abdominal pain with signs of peritoneal irritation. Imaging exams revealed collections confined to the pelvis, plus the presence of an IUD and evidence of sepsis, which was consistent with diffuse peritonitis. An exploratory laparotomy was undertaken, and a ruptured left tubal abscess was found along with peritonitis, and a huge amount of purulent secretion in the pelvis and abdominal cavity. Extensive lavage of the cavities with saline, a left salpingo-oophorectomy, and drainage of the cavities were performed. The histopathological examination of the surgical specimen revealed an acute salpingitis with abscesses containing sulfur granules. Therefore, the diagnosis of abdominal and pelvic actinomycosis was made. The postoperative outcome was troublesome and complicated with a colocutaneous fistula, which drained through the surgical wound. A second surgical approach was needed, requiring another extensive lavage and drainage of the recto-uterine pouch, plus the performance of a colostomy. Broad-spectrum antibiotics added to ampicillin were the first antimicrobial regimen followed by 4 weeks of amoxicillin during the outpatient follow-up. The patient satisfactorily recovered and is already scheduled for the intestinal transit reconstitution.
    Add to my documents.
  23. 23
    Peer Reviewed

    Naproxen Sodium for Pain Control With Intrauterine Device Insertion: A Randomized Controlled Trial.

    Creinin MD

    Obstetrics and Gynecology. 2017 Jun; 129(6):1135-1136.

    Add to my documents.
  24. 24
    Peer Reviewed

    Tale of the Tails, the Missing Postpartum IUCD Strings.

    Mishra S

    Journal of Obstetrics and Gynaecology of India. 2017 Jun; 67(3):202-207.

    INTRODUCTION: Using an intrauterine device (IUD) is many times safer than pregnancy and more effective in preventing pregnancy than oral contraceptives, condoms, spermicidal, any barrier method, or natural family planning. Benefits of healthy timing and spacing of pregnancy are many. Postpartum contraception is becoming popular after introduction of PPIUCD services. OBJECTIVE: To study the incidence, management, clinical outcome of missing strings cases in post-placental and intra-cesarean IUCD. MATERIALS AND METHODS: This study was a retrospective observational study, carried out in the district of Balangir, Odisha, India. Status of women who had post-placental and intra-cesarean IUCD insertion in various institutions between January 2010 and December 2012 having follow-up as per the protocol was taken for the study. All the complications were recorded and studied. Incidence, clinical outcome, and management of missing strings were analyzed. RESULTS: Records of 1343 clients were studied. Six hundred and seventeen cases had failed to report for follow-up as per the study design. Seven hundred and twenty-six cases had follow-up as per the protocol. Of them, 36 had expulsion, and rest 690 cases were taken for the study. There were 209 missing strings at 3 months. At the end of the study, there was spontaneous descend in 138 cases. More than 50 % cases were asymptomatic. Ultrasonography was the method of diagnosis, and simple sounding of the uterus alone could also establish IUD in uterine cavity. Removal rate was higher in missing strings group, Continuation rate is higher in String visible group. CONCLUSION: Post-placental intra-cesarean Copper T 380A insertion is a safe and effective method of reversible contraception; missing string is emerging as a potential distracter of its use. It is important that every user must be followed up and the providers must be competent in managing complication. Better after care in form of effective follow-up and complication management is needed to maintain popularity. Introduction of compensation scheme will also help improving the acceptance.
    Add to my documents.
  25. 25
    Peer Reviewed

    Levonorgestrel-releasing intrauterine contraceptive device in the peritoneal cavity: A report of two cases.

    Staric KD; Taneska P; Zore A; Lukanovic A; Kobal B; Cvjeticanin B; Jakopic K

    Journal of Reproductive Medicine. 2017 Mar-Apr; 62(3-4):215-217.

    BACKGROUND: In modern gynecology an intrauterine device (IUD) with levonorgestrel is often used as a method of contraception. The levonorgestrel-releasing intrauterine system is small and T-shaped. In Slovenia, only a gynecologist may insert it. CASES: We present 2 clinical cases in which, despite strong evidence that no perforation had occurred during insertion, the IUD was found outside the uterus. If the IUD threads are not visible or the IUD cannot be located in the uterine cavity, an X-ray of the abdomen must be performed. If the IUD is found in the abdominal cavity outside the uterus, removal by laparoscopy is carried out. CONCLUSION: Given the large number of inserted IUDs, the complications associated with the levonorgestrel-releasing intrauterine system are quite rare, and therefore it remains one of the most widely used contraceptive methods.
    Add to my documents.